Founded in 2018, Peptone specializes in novel therapeutics for Intrinsically Disordered Proteins (IDPs), linked to inflammatory diseases such as cancer. Their approach integrates biophysics, supercomputing, and machine learning, now advancing in their labs.

Some insights
Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2018
  • Number of employees in Switzerland
    20-49
Key business

You may also be interested in